This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| COVID-19 | 647 |
| SARS | 224 |
| CoV-2 | 155 |
| Dermatol | 83 |
| COVID‐19 | 78 |
| sha | 77 |
| Coronavirus | 73 |
| DOI | 69 |
| China | 67 |
| Italy | 57 |
| Dermatology | 50 |
| DIC | 50 |
| nan | 50 |
| Disease | 46 |
| pemphigus | 44 |
| Wuhan | 43 |
| • | 37 |
| May | 36 |
| Turkey | 34 |
| Table | 34 |
| COVID | 33 |
| Health | 32 |
| ACE2 | 32 |
| April | 31 |
| N95 | 30 |
| March | 28 |
| Pandemic | 27 |
| PCR | 25 |
| COVID19 | 25 |
| ICU | 24 |
| ED | 24 |
| PPE | 23 |
| Kawasaki | 20 |
| Hospital | 20 |
| CLL | 20 |
| hydroxychloroquine | 19 |
| IL-23 | 18 |
| Infection | 18 |
| st | 17 |
| mg | 17 |
| aFGF | 17 |
| TNF | 17 |
| PASI | 17 |
| Department | 17 |
| apremilast | 16 |
| Spain | 16 |
| CD147 | 16 |
| Goldust | 15 |
| A | 15 |
| Covid-19 | 15 |
| HS | 15 |
| University | 15 |
| rh | 15 |
| pernio | 14 |
| nd | 14 |
| Ther | 14 |
| SARS‐CoV‐2 | 14 |
| Clinical | 14 |
| Chilblain | 14 |
| Mohamad | 13 |
| Control | 13 |
| Hydroxychloroquine | 13 |
| IL-6 | 13 |
| Review | 13 |
| Teledermatology | 13 |
| World | 13 |
| dupilumab | 13 |
| Treatment | 12 |
| Novel | 12 |
| IL-17 | 12 |
| February | 12 |
| Dermatologic | 12 |
| CoV2 | 12 |
| AR | 12 |
| IgG | 11 |
| Care | 11 |
| 11 | |
| HCW | 11 |
| II | 11 |
| Medical | 11 |
| IgM | 11 |
| RT | 11 |
| Patient | 11 |
| June | 11 |
| Prevention | 10 |
| AGEP | 10 |
| DHH | 10 |
| HHV-6 | 10 |
| Organization | 10 |
| India | 10 |
| PubMed | 10 |
| Rituximab | 10 |
| bullosa | 10 |
| methotrexate | 10 |
| α | 10 |
| PV | 9 |
| Apremilast | 9 |
| Cutaneous | 9 |
| EB | 9 |
| HADS | 9 |
| Human | 9 |
| MERS | 9 |
| New | 9 |
| Herpes | 9 |
| Society | 9 |
| artefacta | 9 |
| Syndrome | 9 |
| disease-2019 | 9 |
| dermatology | 9 |
| doc_id | 9 |
| teledermatology | 9 |
| United | 9 |
| TMPRSS2 | 9 |
| R. | 8 |
| Aerosol | 8 |
| Atopic | 8 |
| Dupilumab | 8 |
| Evaluation | 8 |
| Healthcare | 8 |
| IFN | 8 |
| IL-12 | 8 |
| States | 8 |
| zoster | 8 |
| Therapy | 8 |
| US | 8 |
| azithromycin | 8 |
| kg | 8 |
| meta | 8 |
| oseltamivir | 8 |
| pemphigoid | 8 |
| T | 8 |
| Dermatitis | 7 |
| HE | 7 |
| Guidelines | 7 |
| European | 7 |
| ICD-10 | 7 |
| December | 7 |
| Clinic | 7 |
| Center | 7 |
| C | 7 |
| Hidradenitis | 7 |
| Poland | 7 |
| Patients | 7 |
| Study | 7 |
| Petechial | 7 |
| herpes | 7 |
| Trial | 7 |
| purpura | 7 |
| Secukinumab | 7 |
| SOP | 7 |
| Psoriasis | 7 |
| Consensus | 6 |
| GAD-7 | 6 |
| Fig | 6 |
| Emergency | 6 |
| Efficacy | 6 |
| Editor | 6 |
| Journal | 6 |
| Dear | 6 |
| Cov-2 | 6 |
| IgA | 6 |
| CNS | 6 |
| Chinese | 6 |
| Chilblains | 6 |
| CT | 6 |
| CD20 | 6 |
| Article | 6 |
| Analysis | 6 |
| Acute | 6 |
| ARDS | 6 |
| AGP | 6 |
| Management | 6 |
| Lotti | 6 |
| S | 6 |
| Matteo | 6 |
| Risk | 6 |
| Medicine | 6 |
| dermoscopy | 6 |
| da | 6 |
| acitretin | 6 |
| Transmission | 6 |
| Suppurativa | 6 |
| Safety | 6 |
| SLE | 6 |
| SJS | 6 |
| epidermolysis | 6 |
| Respiratory | 6 |
| Pemphigus | 6 |
| Recommendations | 6 |
| Onychomycosis | 6 |
| PHQ-9 | 6 |
| Mohammad | 6 |
| Pneumonia | 6 |
| Purpura | 6 |
| RNA | 6 |
| Recalcati | 6 |
| Case | 5 |
| FDA | 5 |
| East | 5 |
| Drug | 5 |
| DLQI | 5 |
| D | 5 |
| Coronaviruses | 5 |
| CoV | 5 |
| Classification | 5 |
| Area | 5 |
| COPD | 5 |
| C. | 5 |
| Biologics | 5 |
| Association | 5 |
| Andrea | 5 |
| American | 5 |
| Administration | 5 |
| ACE-2 | 5 |
| Francesca | 5 |
| FFR | 5 |
| Northern | 5 |
| Guselkumab | 5 |
| Paolo | 5 |
| Hand | 5 |
| nasopharyngitis | 5 |
| fulminans | 5 |
| Zealand | 5 |
| U | 5 |
| Scopus | 5 |
| Research | 5 |
| PsO | 5 |
| Tongji | 5 |
| purpuric | 5 |
| Middle | 5 |
| Manifestations | 5 |
| MS | 5 |
| International | 5 |
| Insert | 5 |
| IL-1 | 5 |
| Nephrology | 5 |
| Histopathological | 5 |
| IH | 4 |
| IL-4 | 4 |
| IL-13 | 4 |
| IL-10 | 4 |
| Giovanni | 4 |
| I | 4 |
| Herpesvirus | 4 |
| Global | 4 |
| Index | 4 |
| Immunomodulators | 4 |
| Ministry | 4 |
| Iran | 4 |
| JAK | 4 |
| July | 4 |
| Lancet | 4 |
| Lipner | 4 |
| Lombardia | 4 |
| M | 4 |
| Maria | 4 |
| Med | 4 |
| F | 4 |
| National | 4 |
| Faculty | 4 |
| CXCL10 | 4 |
| ELISA | 4 |
| Dr. | 4 |
| Abdelmaksoud | 4 |
| Academy | 4 |
| Alexander | 4 |
| Anti | 4 |
| Anxiety | 4 |
| Australia | 4 |
| Ayman | 4 |
| Azithromycin | 4 |
| Biologic | 4 |
| CD4 | 4 |
| CD8 | 4 |
| CDC | 4 |
| CEBD | 4 |
| CI | 4 |
| Nicola | 4 |
| Cancer | 4 |
| Cerrahpasa | 4 |
| CoV-1 | 4 |
| Cochrane | 4 |
| Di | 4 |
| Doxycycline | 4 |
| Navarini | 4 |
| Dermatological | 4 |
| Nottingham | 4 |
| Unfolding | 4 |
| Venereology | 4 |
| Virus | 4 |
| Zhongfaxincheng | 4 |
| botox | 4 |
| chilblain | 4 |
| covid | 4 |
| eczema | 4 |
| isotretinoin | 4 |
| ixekizumab | 4 |
| livedo | 4 |
| molluscum | 4 |
| morbilliform | 4 |
| petechial | 4 |
| rd | 4 |
| reticularis | 4 |
| secukinumab | 4 |
| tofacitinib | 4 |
| vasculopathy | 4 |
| xerosis | 4 |
| ± | 4 |
| Occupational | 4 |
| Use | 4 |
| tocilizumab | 4 |
| UVA1 | 4 |
| Schwartz | 4 |
| Outbreak | 4 |
| Trends | 4 |
| Pediatric | 4 |
| Pernio | 4 |
| Raynaud | 4 |
| Report | 4 |
| Republic | 4 |
| Retrospective | 4 |
| SPSS | 4 |
| San | 4 |
| Randomized | 4 |
| Science | 4 |
| Singh | 4 |
| Severity | 4 |
| Sweet | 4 |
| Torello | 4 |
| Systematic | 4 |
| Signs | 4 |
| Should | 4 |
| Shari | 4 |
| Thrombosis | 4 |
| IL-8 | 3 |
| Gupta | 3 |
| High | 3 |
| HIV | 3 |
| HHV‐6 | 3 |
| HCV | 3 |
| HCQ | 3 |
| H1N1 | 3 |
| France | 3 |
| George | 3 |
| GPFE | 3 |
| Food | 3 |
| Figure | 3 |
| Federico | 3 |
| 3 | |
| Immunomodulator | 3 |
| Face | 3 |
| Immune | 3 |
| Johnson | 3 |
| Impact | 3 |
| K. | 3 |
| Exposure | 3 |
| Laser | 3 |
| Laboratory | 3 |
| Köebner | 3 |
| Kutlu | 3 |
| Kroumpouzos | 3 |
| Krajewski | 3 |
| Janus | 3 |
| Interleukin | 3 |
| January | 3 |
| Jacek | 3 |
| Italian | 3 |
| Istanbul | 3 |
| Isotretinoin | 3 |
| Iris | 3 |
| Intravascular | 3 |
| F. | 3 |
| B | 3 |
| Emerging | 3 |
| Air | 3 |
| Bardazzi | 3 |
| Autoinflammatory | 3 |
| Assessment | 3 |
| Anna | 3 |
| Androgen | 3 |
| America | 3 |
| Alessia | 3 |
| Adult | 3 |
| Body | 3 |
| Adalimumab | 3 |
| Acral | 3 |
| Accepted | 3 |
| ANA | 3 |
| A. | 3 |
| 8) | 3 |
| Lidia | 3 |
| Bhargava | 3 |
| CCL2 | 3 |
| Ebola | 3 |
| Counseling | 3 |
| EM | 3 |
| Dursun | 3 |
| Dong | 3 |
| Diseases | 3 |
| Daniele | 3 |
| DRESS | 3 |
| Cyclosporine | 3 |
| Continued | 3 |
| CCS | 3 |
| Coagulopathy | 3 |
| Claudio | 3 |
| Chloroquine | 3 |
| Chi | 3 |
| Cases | 3 |
| Carugno | 3 |
| COV-2 | 3 |
| Latin | 3 |
| p=0.03 | 3 |
| M. | 3 |
| Varicella | 3 |
| Zhi | 3 |
| Zhang | 3 |
| Zalaudek | 3 |
| Workers | 3 |
| Wake | 3 |
| Vestita | 3 |
| Ventilation | 3 |
| Valeria | 3 |
| ageusia | 3 |
| Uncertain | 3 |
| USA | 3 |
| Tulsa | 3 |
| Tocilizumab | 3 |
| Times | 3 |
| Time | 3 |
| Test | 3 |
| Zoster | 3 |
| etanercept | 3 |
| Szepietowski | 3 |
| petechia | 3 |
| Magnano | 3 |
| κB | 3 |
| Łukasz | 3 |
| Ömer | 3 |
| zona | 3 |
| thrombogenic | 3 |
| tele | 3 |
| pembrolizumab | 3 |
| foliaceus | 3 |
| pandemic | 3 |
| neutrophilic | 3 |
| neurotropic | 3 |
| n=27 | 3 |
| mofetil | 3 |
| lentigo | 3 |
| key | 3 |
| Task | 3 |
| immunomodulator | 3 |
| Systemic | 3 |
| Morbilliform | 3 |
| Pityriasis | 3 |
| Piotr | 3 |
| Pemphigoid | 3 |
| Pearson | 3 |
| Pacifico | 3 |
| PT | 3 |
| Natural | 3 |
| Milan | 3 |
| RED | 3 |
| Michelangelo | 3 |
| Methotrexate | 3 |
| Meta | 3 |
| Medscape | 3 |
| Matusiak | 3 |
| Switzerland | 3 |
| Mann | 3 |
| Practices | 3 |
| PAPR | 3 |
| Rafał | 3 |
| Scholar | 3 |
| Statsoft | 3 |
| Rash | 3 |
| Statistica | 3 |
| StatPearls | 3 |
| Southern | 3 |
| Shashank | 3 |
| Settings | 3 |
| Scientific | 3 |
| Sharma | 3 |
| Surface | 3 |
| SIDeMaST | 3 |
| S1 | 3 |
| Rudnicka | 3 |
| Robert | 3 |
| Respirators | 3 |
| Registry | 3 |
| HR | 2 |
| Helsinki | 2 |
| Hassan | 2 |
| Haemostasis | 2 |
| Group | 2 |
| Goodarzi | 2 |
| HEPA | 2 |
| Grabbe | 2 |
| Hemangiomas | 2 |
| H | 2 |
| INR | 2 |
| Hemostasis | 2 |
| I. | 2 |
| IHS4 | 2 |
| III | 2 |
| IL | 2 |
| IL‐17 | 2 |
| IP10 | 2 |
| Giuffrida | 2 |
| IPC | 2 |
| IRCCS | 2 |
| Giulio | 2 |
| Facepiece | 2 |
| Gisondi | 2 |
| Genome | 2 |
| IV | 2 |
| Equipment | 2 |
| Erbakan | 2 |
| FA | 2 |
| FFP | 2 |
| Fahimeh | 2 |
| Faisal | 2 |
| Features | 2 |
| Federica | 2 |
| Fig1 | 2 |
| Firas | 2 |
| First | 2 |
| Force | 2 |
| Forms | 2 |
| Francesco | 2 |
| G. | 2 |
| Gambini | 2 |
| Gautret | 2 |
| Gene | 2 |
| General | 2 |
| Geneva | 2 |
| IRCSS | 2 |
| Man | 2 |
| Immunohistochemical | 2 |
| Li | 2 |
| Livedo | 2 |
| Lockdown | 2 |
| Lombardy | 2 |
| Luigi | 2 |
| Luo | 2 |
| MCP-1 | 2 |
| MRP | 2 |
| MSM | 2 |
| Macedonia | 2 |
| Malagoli | 2 |
| Male | 2 |
| Epidermolysis | 2 |
| Marco | 2 |
| Mario | 2 |
| Marta | 2 |
| Martin | 2 |
| Mazzatenta | 2 |
| Measures | 2 |
| Meo | 2 |
| Metin | 2 |
| Model | 2 |
| Liu | 2 |
| Leila | 2 |
| Infantile | 2 |
| Laura | 2 |
| Infectious | 2 |
| Infezione | 2 |
| Infliximab | 2 |
| Institute | 2 |
| Interleukin-6 | 2 |
| J. | 2 |
| Jafferany | 2 |
| Jakhar | 2 |
| Joanna | 2 |
| Jose | 2 |
| Juan | 2 |
| Kapoor | 2 |
| Kassir | 2 |
| Katerina | 2 |
| Kruskal | 2 |
| Kumar | 2 |
| L. | 2 |
| LHR | 2 |
| LIBERTY | 2 |
| LR | 2 |
| Langerhans | 2 |
| Epub | 2 |
| Colleges | 2 |
| Epidemiology | 2 |
| Alopecia | 2 |
| Ang | 2 |
| Ang-(1 | 2 |
| Angiotensin | 2 |
| Annalisa | 2 |
| Antibodies | 2 |
| Antiphospholipid | 2 |
| Associated | 2 |
| Autoantibodies | 2 |
| Aykut | 2 |
| Azadeh | 2 |
| BIOBADADERM | 2 |
| Balestri | 2 |
| Barcelona | 2 |
| Based | 2 |
| Behçet | 2 |
| Bing | 2 |
| Bologna | 2 |
| Bragazzi | 2 |
| C3a | 2 |
| C4d | 2 |
| CAPE | 2 |
| Al‐Niaimi | 2 |
| Almutairi | 2 |
| Epidemic | 2 |
| Ali | 2 |
| Murrell | 2 |
| +16/+3 | 2 |
| +2 | 2 |
| +25 | 2 |
| +3 | 2 |
| +34 | 2 |
| +4 | 2 |
| -1 | 2 |
| 2019-nCOV | 2 |
| 706vpjsv | 2 |
| 7t647fww | 2 |
| ADDI | 2 |
| AIFA | 2 |
| AIFM | 2 |
| Abdollahimajd | 2 |
| Address | 2 |
| Adults | 2 |
| Advice | 2 |
| Agents | 2 |
| Airborne | 2 |
| Ajay | 2 |
| CINAHL | 2 |
| CLE | 2 |
| COV | 2 |
| COVID-2019 | 2 |
| De | 2 |
| Deaf | 2 |
| Declaration | 2 |
| Dedee | 2 |
| Dermatologists | 2 |
| Diagnosis | 2 |
| Digitate | 2 |
| Dihydrotestosterone | 2 |
| Dipali | 2 |
| Disease-2019 | 2 |
| Disease‐2019 | 2 |
| Doctor | 2 |
| Dr | 2 |
| EASI | 2 |
| EGFR | 2 |
| ER | 2 |
| Eczema | 2 |
| Effect | 2 |
| Elisa | 2 |
| English | 2 |
| Eosinopenia | 2 |
| Damiani | 2 |
| Damevska | 2 |
| DNA | 2 |
| Comparison | 2 |
| Camilla | 2 |
| Carlo | 2 |
| Casas | 2 |
| Centre | 2 |
| Certolizumab | 2 |
| Chan | 2 |
| Clinics | 2 |
| Coagulation | 2 |
| Colchicine | 2 |
| Consortium | 2 |
| DAPSA | 2 |
| Consultation | 2 |
| Contaminants | 2 |
| Corona | 2 |
| Coronavirus-2 | 2 |
| Corticosteroids | 2 |
| Council | 2 |
| Country | 2 |
| Cross | 2 |
| Curfew | 2 |
| Mueller | 2 |
| ACD | 2 |
| Mycophenolate | 2 |
| alopecia | 2 |
| anti | 2 |
| antiphospholipid | 2 |
| attuative | 2 |
| biocidal | 2 |
| brodalumab | 2 |
| bullous | 2 |
| chronicus | 2 |
| clinicopathological | 2 |
| committee | 2 |
| contagiosum | 2 |
| covid-19 | 2 |
| decretolegge | 2 |
| del | 2 |
| dermatitis | 2 |
| dermoscopic | 2 |
| disposizioni | 2 |
| enzyme-2 | 2 |
| eruption | 2 |
| erythema | 2 |
| erythromelalgia | 2 |
| exanthema | 2 |
| anaphylotoxin | 2 |
| affetti | 2 |
| gb | 2 |
| acrocyanosis | 2 |
| Vahidnezhad | 2 |
| Vezzoli | 2 |
| Viktor | 2 |
| W. | 2 |
| Wai | 2 |
| Wallis | 2 |
| Wang | 2 |
| Washington | 2 |
| Whitney | 2 |
| Women | 2 |
| Worldwide | 2 |
| Wound | 2 |
| Wroclaw | 2 |
| Xue | 2 |
| YAG | 2 |
| Ye | 2 |
| Young | 2 |
| Youssefian | 2 |
| Za | 2 |
| Zhonghua | 2 |
| acral | 2 |
| febbraio | 2 |
| glue | 2 |
| Urticarial | 2 |
| polyangiitis | 2 |
| pseudochilblain | 2 |
| pustular | 2 |
| rash | 2 |
| review | 2 |
| rh‐aFGF | 2 |
| risankizumab | 2 |
| rt | 2 |
| sars | 2 |
| simplex | 2 |
| spectrum | 2 |
| spongiosis | 2 |
| tetracycline | 2 |
| thrombi | 2 |
| vulgaris | 2 |
| ® | 2 |
| × | 2 |
| γ | 2 |
| ‡ | 2 |
| −12 | 2 |
| −4/ | 2 |
| N | 2 |
| prednisone | 2 |
| perivascular | 2 |
| half‐face | 2 |
| paracetamol | 2 |
| inperson | 2 |
| ketoconazole | 2 |
| kinase | 2 |
| lichen | 2 |
| lopinavir | 2 |
| macular | 2 |
| maculopapular | 2 |
| malattie | 2 |
| medRxiv | 2 |
| medrogestone | 2 |
| meningitidis | 2 |
| multicentre | 2 |
| mycophenolate | 2 |
| neuralgia | 2 |
| oligodendroglioma | 2 |
| onychomycosis | 2 |
| p<0.0001 | 2 |
| p<0.01 | 2 |
| p=0.023 | 2 |
| p>0.05 | 2 |
| palmoplantar | 2 |
| Vademecum | 2 |
| https://orcid.org/0000-0002-9615-1246 | 2 |
| Unit | 2 |
| Piergiorgio | 2 |
| Pourani | 2 |
| Preferred | 2 |
| Presence | 2 |
| President | 2 |
| Prignano | 2 |
| Priorities | 2 |
| Propranolol | 2 |
| Protection | 2 |
| Protective | 2 |
| PsA | 2 |
| Questionnaire | 2 |
| Quick | 2 |
| RAAS | 2 |
| RAC | 2 |
| RCTs | 2 |
| Rapid | 2 |
| Rathod | 2 |
| Recep | 2 |
| Receptor | 2 |
| Rech | 2 |
| Regional | 2 |
| Potential | 2 |
| Phototherapeutic | 2 |
| Reticularis | 2 |
| Personnel | 2 |
| N. | 2 |
| NF | 2 |
| Ulteriori | 2 |
| Necmettin | 2 |
| November | 2 |
| Ocrelizumab | 2 |
| Oncology | 2 |
| Oral | 2 |
| Outpatient | 2 |
| Overall | 2 |
| Oxford | 2 |
| PCO | 2 |
| Pamela | 2 |
| Pan | 2 |
| Papulosquamous | 2 |
| Part | 2 |
| Pathological | 2 |
| Pavia | 2 |
| Pediatr | 2 |
| Pediatrics | 2 |
| Personal | 2 |
| Residents | 2 |
| Platform | 2 |
| Rev | 2 |
| Stability | 2 |
| Stefano | 2 |
| Stephan | 2 |
| Stevens | 2 |
| Structure | 2 |
| Summary | 2 |
| Surgery | 2 |
| Swathi | 2 |
| Szepietowska | 2 |
| TOCC | 2 |
| Target | 2 |
| Team | 2 |
| Temiz | 2 |
| Terbinafine | 2 |
| Th17 | 2 |
| Thailand | 2 |
| Tofacitinib | 2 |
| Training | 2 |
| Tursen | 2 |
| UK | 2 |
| UPLA | 2 |
| URIs | 2 |
| Staphylococcus | 2 |
| Steven | 2 |
| SPG | 2 |
| Sex | 2 |
| Rheumatology | 2 |
| Roberta | 2 |
| Robustelli | 2 |
| Rome | 2 |
| Roxanna | 2 |
| Spectrum | 2 |
| Sadoughifar | 2 |
| Selami | 2 |
| Sena | 2 |
| Ricardo | 2 |
| Series | 2 |
| Reza | 2 |
| Shapiro | 2 |
| Shivakumar | 2 |
| Simeonovski | 2 |
| Simon | 2 |
| Singapore | 2 |
| Sjogren | 2 |
| Skopje | 2 |
| South | 2 |
| Imberti | 1 |
| Iman | 1 |
| Images | 1 |
| Imag | 1 |
| INDERCOS | 1 |
| Illinois | 1 |
| Ill | 1 |
| IgG. | 1 |
| IVIG | 1 |
| IT | 1 |
| Immunobiology | 1 |
| Immunobiological | 1 |
| Inc. | 1 |
| Immunobullous | 1 |
| Immunofluorescent | 1 |
| Immunogenicity | 1 |
| Immunospress | 1 |
| Immunospressive | 1 |
| Immunosuppressant | 1 |
| Improvement | 1 |
| InCites | 1 |
| Inamdar | 1 |
| ILDS | 1 |
| Indian | 1 |
| IL‐23 | 1 |
| Hosp | 1 |
| ILD | 1 |
| IL12 | 1 |
| Induction | 1 |
| Histopathology | 1 |
| Hononary | 1 |
| Hopkins | 1 |
| Histological | 1 |
| Hsien | 1 |
| Hubei | 1 |
| Hui | 1 |
| Hunt | 1 |
| Hunter | 1 |
| Hurley | 1 |
| Hydrogel | 1 |
| IADVL | 1 |
| ICD | 1 |
| IE | 1 |
| IL)‐17 | 1 |
| IL-12/23p40-targeted | 1 |
| IL-17secretion | 1 |
| IL-1β | 1 |
| IL-2 | 1 |
| IL-23p19-targeted | 1 |
| IL-6R | 1 |
| IL-7 | 1 |
| Indrashis | 1 |
| Kenneth | 1 |
| Influence | 1 |
| Jamilly | 1 |
| Jerry | 1 |
| Jin | 1 |
| Jindal | 1 |
| John | 1 |
| Johns | 1 |
| Jouni | 1 |
| Judge | 1 |
| K | 1 |
| KAP | 1 |
| Kamal | 1 |
| Kamlakar | 1 |
| Kanaris | 1 |
| Kandhari | 1 |
| Karthika | 1 |
| Kaur | 1 |
| Kaushik | 1 |
| Kazemi | 1 |
| Kevser | 1 |
| Keyun | 1 |
| Khalaf | 1 |
| Kindler | 1 |
| Kingdom | 1 |
| Hesham | 1 |
| Janniger | 1 |
| Jak | 1 |
| Influenza | 1 |
| Jack | 1 |
| Inhibitors | 1 |
| Initiating | 1 |
| Institutions | 1 |
| Interferones | 1 |
| Interferonopathies | 1 |
| Internal | 1 |
| Internatinal | 1 |
| Internationale | 1 |
| Interventions | 1 |
| Intraepidermal | 1 |
| Intubation | 1 |
| Irena | 1 |
| Isabela | 1 |
| Ishmeet | 1 |
| Island | 1 |
| Isoletta | 1 |
| Istituto | 1 |
| Items | 1 |
| Ixekizumab | 1 |
| JAK1 | 1 |
| JAK2 | 1 |
| JAK3 | 1 |
| JHU | 1 |
| Histologic | 1 |
| Farnoosh | 1 |
| Herpesviridae | 1 |
| Fig4 | 1 |
| Filippi | 1 |
| Filippo | 1 |
| Filtration | 1 |
| Floel | 1 |
| Fluid | 1 |
| Fondazione | 1 |
| Forces | 1 |
| Fortina | 1 |
| Franco | 1 |
| Front | 1 |
| Full | 1 |
| Fulminans | 1 |
| Function | 1 |
| Future | 1 |
| G.R.R. | 1 |
| GA | 1 |
| GG | 1 |
| GM | 1 |
| GPs | 1 |
| GU | 1 |
| Gabriella | 1 |
| Gaia | 1 |
| Gallizzi | 1 |
| Figs | 1 |
| Fig3 | 1 |
| Ganiyat | 1 |
| Fig2 | 1 |
| Fabio | 1 |
| Fabiola | 1 |
| Facilities | 1 |
| Factor | 1 |
| Factors | 1 |
| Family | 1 |
| Fang | 1 |
| Farabi | 1 |
| Koebner | 1 |
| Fata | 1 |
| Fatality | 1 |
| Fatih | 1 |
| Favalli | 1 |
| Favipiravir | 1 |
| Favipravir | 1 |
| Feasibility | 1 |
| February-8 | 1 |
| Fedratinib | 1 |
| Feily | 1 |
| Female | 1 |
| Fernanda | 1 |
| Fibroblast | 1 |
| Fig.1 | 1 |
| Galván | 1 |
| Gaspari | 1 |
| Hepatitis | 1 |
| Gualdi | 1 |
| Guida | 1 |
| Guidance | 1 |
| Guide | 1 |
| Guillain | 1 |
| Guilpain | 1 |
| Gulhima | 1 |
| HIFU | 1 |
| HIV-1 | 1 |
| HLH | 1 |
| HPV | 1 |
| HSV-1 | 1 |
| HTN | 1 |
| HUNT | 1 |
| HV | 1 |
| HZ | 1 |
| Habibullah | 1 |
| Hanlin | 1 |
| Hatanaka | 1 |
| HeLa | 1 |
| Healing | 1 |
| Heba | 1 |
| Height | 1 |
| Hematologic | 1 |
| Guarneri | 1 |
| Gu | 1 |
| Gaurav | 1 |
| Growth | 1 |
| Generale | 1 |
| Genomewide | 1 |
| Ghasem | 1 |
| Giacalone | 1 |
| Gianlorenzo | 1 |
| Gianluca | 1 |
| Gillian | 1 |
| Gionathan | 1 |
| Giorgini | 1 |
| Girardelli | 1 |
| Girlane | 1 |
| Giulia | 1 |
| Giuliani | 1 |
| Giuseppe | 1 |
| Glutaraldehyde | 1 |
| Good | 1 |
| Goren | 1 |
| Governance | 1 |
| Graduate | 1 |
| Graefe | 1 |
| Grasso | 1 |
| Grayson | 1 |
| Greater | 1 |
| Kit | 1 |
| Members | 1 |
| Kohli | 1 |
| Natasa | 1 |
| Mysore | 1 |
| NK | 1 |
| NS | 1 |
| NaCl | 1 |
| Nada | 1 |
| Nadeem | 1 |
| Najar | 1 |
| Najdova | 1 |
| Name | 1 |
| Naples | 1 |
| Nasopharyngeal | 1 |
| Nawaf | 1 |
| Kolmogorov | 1 |
| Nazzaro | 1 |
| Nd | 1 |
| Negi | 1 |
| Negin | 1 |
| Neisseria | 1 |
| Nekooghadam | 1 |
| Neloska | 1 |
| Nestor | 1 |
| Neval | 1 |
| Nicole | 1 |
| Niloufar | 1 |
| Muthu | 1 |
| Mutalik | 1 |
| Murat | 1 |
| Munise | 1 |
| Mirian | 1 |
| Mirkamali | 1 |
| Modes | 1 |
| Modified | 1 |
| Mohamed | 1 |
| Mohan | 1 |
| Mohs | 1 |
| Mojtaba | 1 |
| Molina‐Leyva | 1 |
| Monitoring | 1 |
| Monotherapy | 1 |
| Montero‐Vilchez | 1 |
| Monti | 1 |
| Moreira | 1 |
| Mortus | 1 |
| Moscow | 1 |
| Moura | 1 |
| Mozafarpoor | 1 |
| Mrinal | 1 |
| Mucociliary | 1 |
| Mucous | 1 |
| Mugheddu | 1 |
| Multigene | 1 |
| Nisticò | 1 |
| Nobar | 1 |
| Noninferiority | 1 |
| Oliveira | 1 |
| Olszewska | 1 |
| Omalizumab | 1 |
| Oncologic | 1 |
| Ongoing | 1 |
| Online | 1 |
| Operating | 1 |
| Ophthalmological | 1 |
| Ophthalmology | 1 |
| Optimal | 1 |
| Ordóñez‐Rubiano | 1 |
| Organisation | 1 |
| Oriented | 1 |
| Orioni | 1 |
| Oseltamivir | 1 |
| Otezla | 1 |
| Outdoor | 1 |
| Outpatients | 1 |
| Overview | 1 |
| Ozge | 1 |
| Ozgor | 1 |
| PA | 1 |
| PAK1 | 1 |
| PAKs | 1 |
| Olmesartan | 1 |
| Olisova | 1 |
| Nora | 1 |
| Oklahoma | 1 |
| Noronha | 1 |
| North | 1 |
| Northeast | 1 |
| Northwell | 1 |
| Norway | 1 |
| Nosocomial | 1 |
| Novirin | 1 |
| Nunnari | 1 |
| Nurcan | 1 |
| Nurlin | 1 |
| Nutrition | 1 |
| O. | 1 |
| OR=0.04 | 1 |
| OR=0.10 | 1 |
| OR=0.17 | 1 |
| OR=0.42 | 1 |
| OR=1.56 | 1 |
| OR=1.65 | 1 |
| OR=1.86 | 1 |
| OR=1.92 | 1 |
| OR=2.99 | 1 |
| Obesity | 1 |
| Office | 1 |
| Ministers | 1 |
| Microsoft | 1 |
| Micrographic | 1 |
| League | 1 |
| Lebwohl | 1 |
| Lechien | 1 |
| Legend | 1 |
| Lence | 1 |
| Lesions | 1 |
| Leszek | 1 |
| Letter | 1 |
| Leukocytoclastic | 1 |
| Leydig | 1 |
| Lidose | 1 |
| Life | 1 |
| Light | 1 |
| Like | 1 |
| Linear | 1 |
| Literature | 1 |
| Loi | 1 |
| London | 1 |
| Long | 1 |
| Lopinavir | 1 |
| Loredana | 1 |
| Lu | 1 |
| Lucca | 1 |
| Lucchesi | 1 |
| Learning | 1 |
| Lavinia | 1 |
| Luzi | 1 |
| Latent | 1 |
| Komal | 1 |
| Kopra | 1 |
| Korean | 1 |
| Korting | 1 |
| Kotan | 1 |
| Koziatek | 1 |
| Krajewska | 1 |
| Kridin | 1 |
| Krishan | 1 |
| Kumaran | 1 |
| Kutlubay | 1 |
| KyberSept | 1 |
| L.M. | 1 |
| LCV | 1 |
| LE | 1 |
| LY | 1 |
| Labor | 1 |
| Lai | 1 |
| Lallas | 1 |
| Lan | 1 |
| Lange | 1 |
| Lanzoni | 1 |
| Lao | 1 |
| Lung | 1 |
| Lymphocryptoviruses | 1 |
| Microbiologic | 1 |
| Masks | 1 |
| Matricardi | 1 |
| Maxillofac | 1 |
| Maya | 1 |
| Mayo | 1 |
| Mazza | 1 |
| Małgorzata | 1 |
| McCoy | 1 |
| Measurement | 1 |
| Medicare | 1 |
| Medicines | 1 |
| Medium | 1 |
| Mehmet | 1 |
| Melis | 1 |
| FP | 1 |
| Memorandum | 1 |
| Mendonça | 1 |
| Mental | 1 |
| Mercurio | 1 |
| Mersin | 1 |
| Messina | 1 |
| Metrics | 1 |
| Michela | 1 |
| Michelle | 1 |
| Mass | 1 |
| Mask | 1 |
| Lymphoma | 1 |
| Mas | 1 |
| Lymphomas | 1 |
| Lívia | 1 |
| M.G. | 1 |
| MALDI | 1 |
| MD | 1 |
| MEDLINE | 1 |
| MEK | 1 |
| MIP1-α | 1 |
| MM | 1 |
| MMP-2 | 1 |
| MMP-9 | 1 |
| MMPs | 1 |
| Macrophage | 1 |
| Magdalena | 1 |
| Mahe | 1 |
| Maja | 1 |
| Major | 1 |
| Malar | 1 |
| Malavika | 1 |
| Malcom | 1 |
| Malpighi | 1 |
| Mariani | 1 |
| Martinez‐Lopez | 1 |
| Fabbrocini | 1 |
| Dermatologist | 1 |
| FL | 1 |
| Azitromycin | 1 |
| Atomic | 1 |
| Attendings | 1 |
| Atula | 1 |
| Atzori | 1 |
| At‐risk | 1 |
| Australian | 1 |
| Austria | 1 |
| Autoimmun | 1 |
| Axillary | 1 |
| Ayhan | 1 |
| Azathioprine | 1 |
| Azzarelli | 1 |
| FG | 1 |
| B. | 1 |
| B19 | 1 |
| BMI=30.9±5.5 | 1 |
| BRAF | 1 |
| Babu | 1 |
| Bachevski | 1 |
| Bagnato | 1 |
| Banu | 1 |
| Barre | 1 |
| Barrier | 1 |
| Barros | 1 |
| Athough | 1 |
| Ataseven | 1 |
| Atak | 1 |
| Associations | 1 |
| Anupam | 1 |
| Anuradha | 1 |
| Apis | 1 |
| Application | 1 |
| Aquino | 1 |
| Arabia | 1 |
| Arash | 1 |
| Araújo | 1 |
| Arbidol | 1 |
| Arch | 1 |
| Archive | 1 |
| Area>10 | 1 |
| Argent | 1 |
| Armed | 1 |
| Arora | 1 |
| Arosio | 1 |
| Arun | 1 |
| Arzu | 1 |
| Aseem | 1 |
| Asia | 1 |
| Askin | 1 |
| Asokan | 1 |
| Asplenic | 1 |
| Barruscotti | 1 |
| Baseline | 1 |
| Basics | 1 |
| Bortoluzzi | 1 |
| Boxley | 1 |
| Brachman | 1 |
| Brandão | 1 |
| Brazzelli | 1 |
| British | 1 |
| Bullae | 1 |
| Bullous | 1 |
| C-50 | 1 |
| C.R. | 1 |
| C5b_9 | 1 |
| CBC | 1 |
| CD147-targeted | 1 |
| CD151 | 1 |
| CD19-dependent | 1 |
| CFR | 1 |
| CLIA | 1 |
| CMLS | 1 |
| CO | 1 |
| COL7A1 | 1 |
| COLCORONA | 1 |
| CONCLUSION | 1 |
| CORONAVIRUS‐DAYS | 1 |
| COVI-19 | 1 |
| Box | 1 |
| Bonferroni | 1 |
| Bassi | 1 |
| Bonferonni | 1 |
| Battista | 1 |
| Battle | 1 |
| Beard | 1 |
| Behavior | 1 |
| Belloni | 1 |
| Belma | 1 |
| Belo | 1 |
| Bennardo | 1 |
| Bennett | 1 |
| Benzonatate | 1 |
| Bergamo | 1 |
| Beth | 1 |
| Better | 1 |
| Beyzaee | 1 |
| Białynicki‐Birula | 1 |
| Bibilash | 1 |
| BioCAPTURE | 1 |
| Biological | 1 |
| Biłynicki‐Birula | 1 |
| Blicharz | 1 |
| Blind | 1 |
| Board | 1 |
| Bolognia | 1 |
| Antonella | 1 |
| Anticoagulant | 1 |
| Antibody | 1 |
| 2019‐first | 1 |
| 3a96ada622a1d763ffff8b53cfb90d0de994ec11 | 1 |
| 6Others | 1 |
| 6nq3jwgr | 1 |
| 7j3xirfg | 1 |
| 8,11,20 | 1 |
| 8xk4dt7 | 1 |
| 97239b8c8b360ba0aa5d692392824c7a363948e5 | 1 |
| 9Others | 1 |
| A.M.B. | 1 |
| A.P. | 1 |
| A1 | 1 |
| AAD | 1 |
| ABBREVIATIONS | 1 |
| ACE | 1 |
| ACEi | 1 |
| ACS | 1 |
| AE | 1 |
| AEs | 1 |
| AGEP(Acute | 1 |
| AGEP)-results | 1 |
| AGP's)PPE | 1 |
| AIBD | 1 |
| AIOM | 1 |
| 26649970b107bb626616ce4f2a2cde4c0b766856 | 1 |
| 0pi3wcv5 | 1 |
| ALLIANCE | 1 |
| 0nhsf90c | 1 |
| PDE4 | 1 |
| +13/ | 1 |
| +17,+33 | 1 |
| +18 | 1 |
| --is | 1 |
| -2 | 1 |
| -30 | 1 |
| -31 | 1 |
| -4 | 1 |
| -4/ | 1 |
| -45 | 1 |
| -48 | 1 |
| -71/-13 | 1 |
| -9 | 1 |
| -COV2 | 1 |
| -Indian | 1 |
| -Like | 1 |
| -ethics | 1 |
| .0012 | 1 |
| .0044 | 1 |
| /acne | 1 |
| /s | 1 |
| 0bi2f3 | 1 |
| AL | 1 |
| ALPA | 1 |
| Anpilogova | 1 |
| Aline | 1 |
| Allergologicum | 1 |
| Allergology | 1 |
| Allison | 1 |
| Almasi | 1 |
| Altinisik | 1 |
| Altunkalem | 1 |
| Amerio | 1 |
| Amir | 1 |
| An | 1 |
| Analyses | 1 |
| Anant | 1 |
| Anatomy | 1 |
| Andrej | 1 |
| Andy | 1 |
| Anedoctical | 1 |
| Angelina | 1 |
| Angelo | 1 |
| Angileri | 1 |
| Angiogenesis | 1 |
| Angioimmunoblastic | 1 |
| Anita | 1 |
| Ann | 1 |
| Annapaola | 1 |
| Alkaloids | 1 |
| Alessandra | 1 |
| AMERIO | 1 |
| Alert | 1 |
| AZM | 1 |
| Abnormalities | 1 |
| Absence | 1 |
| Accessed | 1 |
| Activation | 1 |
| Activity | 1 |
| Adebanjo | 1 |
| Adenike | 1 |
| Admissions | 1 |
| Adolescents | 1 |
| Adriana | 1 |
| Aesthetic | 1 |
| Africa | 1 |
| Agarwal | 1 |
| Agency | 1 |
| Agra | 1 |
| Ahmet | 1 |
| Aimilios | 1 |
| Akanksha | 1 |
| Akram | 1 |
| Aktaş | 1 |
| Alberto | 1 |
| Albuquerque | 1 |
| COVID-19-a | 1 |
| COVID-19Hydroxychloroquine | 1 |
| COVID-19Telemedicine | 1 |
| Disarray | 1 |
| Disorder | 1 |
| Disorders | 1 |
| Disparities | 1 |
| Division | 1 |
| Doctors | 1 |
| Document | 1 |
| Dorukhan | 1 |
| Double | 1 |
| Downregulation | 1 |
| Drugs | 1 |
| Drylip | 1 |
| Dua | 1 |
| Duo | 1 |
| Dupuy | 1 |
| Duval | 1 |
| Dynamics | 1 |
| Dystrophic | 1 |
| D‐dimer | 1 |
| E | 1 |
| E.M. | 1 |
| EAACI | 1 |
| EBD | 1 |
| EBV | 1 |
| Discovery | 1 |
| Directorate | 1 |
| EMS | 1 |
| Dinesh | 1 |
| Decree | 1 |
| Deepak | 1 |
| Delfino | 1 |
| Delivery | 1 |
| Delphi | 1 |
| Demosthenous | 1 |
| Dengue | 1 |
| Dental | 1 |
| Dependent | 1 |
| Dermatopathology | 1 |
| Dermatosurgeons | 1 |
| Dermis | 1 |
| Dermo | 1 |
| Dermoscopy | 1 |
| Desmosomes | 1 |
| Development | 1 |
| Dhawan | 1 |
| Dhurat | 1 |
| Diana | 1 |
| Diet | 1 |
| Dimitri | 1 |
| Dimitrovska | 1 |
| Dimova | 1 |
| ECLIPSE | 1 |
| ENA | 1 |
| Daye | 1 |
| Ennio | 1 |
| Environ | 1 |
| Environmental | 1 |
| Eosinophilia | 1 |
| Epidemiologic | 1 |
| Erhan | 1 |
| Eruption | 1 |
| Erythematous | 1 |
| Erzurum | 1 |
| Estates | 1 |
| Estébanez | 1 |
| Etanercept | 1 |
| Ethics | 1 |
| Eugenio | 1 |
| EuroSCAR | 1 |
| Europeand | 1 |
| Evangelista | 1 |
| Evidence | 1 |
| Examination | 1 |
| Excel | 1 |
| Expert | 1 |
| Extended | 1 |
| FFP3 | 1 |
| FFRis | 1 |
| Enrico | 1 |
| England | 1 |
| ESCD | 1 |
| Engineering | 1 |
| ESTEEM | 1 |
| ET | 1 |
| ETFAD | 1 |
| EULAR | 1 |
| Early | 1 |
| Earth | 1 |
| Economic | 1 |
| Eczematous | 1 |
| Ed | 1 |
| Eden | 1 |
| Edge | 1 |
| Education | 1 |
| Effective | 1 |
| Efficiency | 1 |
| Elsaie | 1 |
| El‐Amawy | 1 |
| Eman | 1 |
| Embase | 1 |
| Emollients | 1 |
| Enclosure | 1 |
| Endogenous | 1 |
| Endothelialitis | 1 |
| Endotracheal | 1 |
| Death | 1 |
| Day | 1 |
| COVID_19 | 1 |
| Challenges | 1 |
| Chang | 1 |
| Characteristics | 1 |
| Characterization | 1 |
| Chart | 1 |
| Chatrath | 1 |
| Checkpoint | 1 |
| Chellappan | 1 |
| Chemotherapy | 1 |
| Chen | 1 |
| Chennai | 1 |
| Chhabra | 1 |
| Chiara | 1 |
| Chicago | 1 |
| Chickenpox | 1 |
| Childhood | 1 |
| Children | 1 |
| Chiranjiv | 1 |
| Chloé | 1 |
| Chongqing | 1 |
| Chronic | 1 |
| Chrostowska | 1 |
| Citation | 1 |
| Cittadini | 1 |
| Chander | 1 |
| Cerrahpaşa | 1 |
| Claire | 1 |
| Census | 1 |
| COronaVirus | 1 |
| CRS | 1 |
| CSF | 1 |
| CSSE | 1 |
| CXCL1 | 1 |
| CXCL9 | 1 |
| Caffeic | 1 |
| Cagliari | 1 |
| Callegaro | 1 |
| Camila | 1 |
| Campaign | 1 |
| Campo | 1 |
| Candida | 1 |
| Cannavò | 1 |
| Caporali | 1 |
| Carbomer | 1 |
| Cardiothor | 1 |
| Carlos | 1 |
| Carstairs | 1 |
| Castagna | 1 |
| Cataldo | 1 |
| Category | 1 |
| Catherine | 1 |
| City | 1 |
| Classificationof | 1 |
| Davinder | 1 |
| Coronavirus-19 | 1 |
| Corticosteroid | 1 |
| Costs | 1 |
| Cov-2)-infection | 1 |
| Coverall | 1 |
| Covid19 | 1 |
| Cox | 1 |
| Crisis | 1 |
| Cristina | 1 |
| Crohn | 1 |
| Cynthia | 1 |
| Cytokines | 1 |
| Czuwara | 1 |
| D. | 1 |
| DAB1 | 1 |
| DERMATOLOGY | 1 |
| DHT | 1 |
| DIsease | 1 |
| DJ | 1 |
| Damage | 1 |
| Das | 1 |
| Dastoli | 1 |
| Data | 1 |
| Database | 1 |
| Corporation | 1 |
| Coronaphobia | 1 |
| Cleaning | 1 |
| Cornelia | 1 |
| Clinicopathologic | 1 |
| Cluster | 1 |
| CoV-2-a | 1 |
| CoV. | 1 |
| CoVs | 1 |
| Coletto | 1 |
| Collegium | 1 |
| Colombia | 1 |
| Columbus | 1 |
| Comment | 1 |
| Commission | 1 |
| Committee | 1 |
| Comparative | 1 |
| Complement | 1 |
| Concern | 1 |
| Confirmatory | 1 |
| Conforti | 1 |
| Congress | 1 |
| Conservation | 1 |
| Consultations | 1 |
| Contact | 1 |
| Controlled | 1 |
| Conundrum | 1 |
| PASI50 | 1 |
| burde | 1 |
| PR | 1 |
| f50249f1c5bfd076ed36f06dd2f3ce77c740cd82 | 1 |
| enzalutamide | 1 |
| eosinopenia | 1 |
| ephelides | 1 |
| epidemiologica | 1 |
| epidermidis | 1 |
| epristeride | 1 |
| equipment(PPE)-related | 1 |
| erythroderma | 1 |
| etiopathogenesis | 1 |
| etretinate | 1 |
| exanthamatous | 1 |
| f6777216870a8f8b29b95acb43332c1d96c58afb | 1 |
| bio | 1 |
| f7a587919cf44cbf35aa0e500e51f2e5acbfb95d | 1 |
| f83ebfbe9bdccfeea50ba4640ca1b38923b8d846 | 1 |
| facepiece | 1 |
| fda520238fb80840f75b758949898e414c9b5ec3 | 1 |
| fightingCOVID-19 | 1 |
| figurate | 1 |
| flutamide | 1 |
| fzj3ciif | 1 |
| genital | 1 |
| gering | 1 |
| gestione | 1 |
| efficac | 1 |
| ece92542f03bf99c22d5f01d6ccd842de8df26de | 1 |
| eb5y7gxj | 1 |
| eab7i4f6 | 1 |
| dth.13780 | 1 |
| dth.13805 | 1 |
| dth.13867 | 1 |
| dth.13885 | 1 |
| dth.13896 | 1 |
| dth.13909 | 1 |
| dth.13912 | 1 |
| dth.13926 | 1 |
| dth.13977 | 1 |
| dth.13982 | 1 |
| dth.13996 | 1 |
| dth.14011 | 1 |
| dth.14050 | 1 |
| dth.14172 | 1 |
| dth.14185 | 1 |
| dth.14211 | 1 |
| dth.14220 | 1 |
| dth.14229 | 1 |
| dth.14323 | 1 |
| dysesthesia | 1 |
| dysmetabolic | 1 |
| e3fa51cbec814e4b1bc4001c840f470bec0f9e60 | 1 |
| e50de7b73dd886027f57f2e23e3c63cad26d213e | 1 |
| glycosidase | 1 |
| h08uzro4 | 1 |
| hastaya | 1 |
| hyperkeratosis | 1 |
| hyposmic | 1 |
| immunoassay | 1 |
| immunoassays | 1 |
| immunomodulatory | 1 |
| immunopathogenesis | 1 |
| immunostimulatory | 1 |
| immunosuppressor | 1 |
| improveme | 1 |
| indicazioni | 1 |
| infantum | 1 |
| infliximab | 1 |
| institutes | 1 |
| institutional | 1 |
| interferonopathies | 1 |
| international | 1 |
| interstitiopathy | 1 |
| intraepidermal | 1 |
| inversa | 1 |
| ipilimumab | 1 |
| isotypes | 1 |
| j1sg46w9 | 1 |
| j9p7ahl8 | 1 |
| janus | 1 |
| hyperostosis | 1 |
| hyperexpression | 1 |
| hbcu72 | 1 |
| https://trends.google.com/trends/?geo=TR | 1 |
| health | 1 |
| healthcare | 1 |
| hedgehog | 1 |
| hematoxylin | 1 |
| hepatitis | 1 |
| hepatoprotective | 1 |
| herpesvirus | 1 |
| herpesvirus-6 | 1 |
| herpesviruses | 1 |
| herpeticum | 1 |
| hfuvm1oh | 1 |
| hidradenitits | 1 |
| high‐epidemic | 1 |
| high‐risk | 1 |
| histopathologic | 1 |
| homequarantine | 1 |
| host‐virus | 1 |
| https:// | 1 |
| https://orcid.org/0000-0002-2390-6505Alessia | 1 |
| https://orcid.org/0000-0002-5997-2045 | 1 |
| https://orcid.org/0000-0002-9455-4025Mohamad | 1 |
| https://orcid.org/0000-0003-0840-1936Mohamad | 1 |
| https://orcid.org/0000-0003-1589-9672 | 1 |
| dth.13769 | 1 |
| dth.13749 | 1 |
| dth.13745 | 1 |
| coagulopathic | 1 |
| congress | 1 |
| contenimento | 1 |
| cord-254628 | 1 |
| cord-258039 | 1 |
| cord-263882-s5oxr6es | 1 |
| cord-264264 | 1 |
| cord-277693 | 1 |
| cord-277971 | 1 |
| cord-280774-r2xm164s | 1 |
| cord-281216 | 1 |
| cord-284158 | 1 |
| cord-287013 | 1 |
| cord-289819 | 1 |
| cord-289855 | 1 |
| cord-293711-qgefn164 | 1 |
| cord-296022-yl3j2x5p | 1 |
| cord-297400-l8fhy1hu | 1 |
| cord-301107 | 1 |
| cord-302571-vb9ks4mq | 1 |
| cord-303460-abutfxtf | 1 |
| cord-306070 | 1 |
| cord-309813-qojacnli | 1 |
| cord-317323-wp3vh4c1 | 1 |
| colchicine | 1 |
| cm | 1 |
| cord-319820-eb5y7gxj | 1 |
| clobetasol | 1 |
| blegen | 1 |
| board | 1 |
| bollose | 1 |
| bologna | 1 |
| bprnq9wx | 1 |
| bronchoalveolar | 1 |
| bruton | 1 |
| c. | 1 |
| c5baecdf2d5f3aa6c8ba67a0a6a7c6e665928328 | 1 |
| calciphylaxis | 1 |
| cariostatic | 1 |
| case | 1 |
| cc04931be0bb0e0ec8d8f87a44b020a26adcfc47 | 1 |
| cdc25C | 1 |
| ce33b79d22f4c5bca3d86e9a6d4a793be94682b6 | 1 |
| ce995b67ddae1e9da7ecf4c819a1354f499c1ac0 | 1 |
| cf0ca7e3cd21553c3ac2cec8f8301e3045224563 | 1 |
| chemiluminescent | 1 |
| chemoattractant | 1 |
| chemoprophylaxis | 1 |
| chevron | 1 |
| chi | 1 |
| chloroquine | 1 |
| cord-318866 | 1 |
| cord-322718-zpf2ri9k | 1 |
| dth.13713 | 1 |
| dermatol | 1 |
| desmoglein-1 | 1 |
| desmoglein-3 | 1 |
| desmosomal | 1 |
| di | 1 |
| dienogest | 1 |
| diferential | 1 |
| diffuse | 1 |
| disease | 1 |
| drospirenone | 1 |
| dth.13365 | 1 |
| dth.13383 | 1 |
| dth.13421 | 1 |
| dth.13434 | 1 |
| dth.13437 | 1 |
| dth.13475 | 1 |
| dth.13482 | 1 |
| dth.13506 | 1 |
| dth.13593 | 1 |
| dth.13597 | 1 |
| dth.13630 | 1 |
| dth.13676 | 1 |
| dth.13697 | 1 |
| dth.13709 | 1 |
| dermatosis | 1 |
| dermapen | 1 |
| cord-323965 | 1 |
| dentistry | 1 |
| cord-324794-h08uzro4 | 1 |
| cord-334933-br1cr8kj | 1 |
| cord-335104 | 1 |
| cord-340474-hbcu72 | 1 |
| cord-346159 | 1 |
| cord-348430 | 1 |
| cordon | 1 |
| corona | 1 |
| coronavirus | 1 |
| coronavírus | 1 |
| cov-2 | 1 |
| cross‐sectional | 1 |
| cryoglobulinemia | 1 |
| cryotherapy | 1 |
| cutanea | 1 |
| cyclophilin | 1 |
| cyclophilins | 1 |
| cyproterone | 1 |
| d8fbc8b5aac56767a5e0830a47ad816c85166f54 | 1 |
| da516a5f665fcb8a6f3a1fd350bcfa34820d951a | 1 |
| ddfbb6cf0e5d0119fbad7885d12487330b45fe2b | 1 |
| decessi | 1 |
| dell'emergenza | 1 |
| journal | 1 |
| kaempferol | 1 |
| kjoi54ea | 1 |
| standart | 1 |
| subungual | 1 |
| sui | 1 |
| sulfonamides | 1 |
| sull | 1 |
| superiore | 1 |
| surveilla | 1 |
| syndet | 1 |
| syndrome | 1 |
| syndromic | 1 |
| t3z6ghyp | 1 |
| targetoid | 1 |
| temporal | 1 |
| tetraspanin | 1 |
| therapy | 1 |
| tildrakizumab | 1 |
| topics(n=50 | 1 |
| topilutamide | 1 |
| tqlg5bac | 1 |
| treatment | 1 |
| trimegestone | 1 |
| tyrosine | 1 |
| ua69gcxv | 1 |
| uabnyomr | 1 |
| staphylococcus | 1 |
| square | 1 |
| university | 1 |
| spironolactone | 1 |
| qojacnli | 1 |
| r0fhnpdn | 1 |
| range | 1 |
| red‐zone | 1 |
| region | 1 |
| rhinovirus-- | 1 |
| rosae | 1 |
| s5oxr6es | 1 |
| sars‐cov‐2 | 1 |
| selfinflicted | 1 |
| serine | 1 |
| sertraline | 1 |
| service | 1 |
| seviteronel | 1 |
| shea | 1 |
| siRNA | 1 |
| sidemast.org/blog/coronavirus | 1 |
| single‐center | 1 |
| single‐use | 1 |
| smhto9em | 1 |
| soapthe | 1 |
| sollv92j | 1 |
| sonic | 1 |
| ultraviolet | 1 |
| urgenti | 1 |
| pulmona | 1 |
| İsa | 1 |
| β-2-glycoprotein1 | 1 |
| ‐41 | 1 |
| ‐44 | 1 |
| −1 | 1 |
| −10 | 1 |
| −15 | 1 |
| −2 | 1 |
| −25 | 1 |
| −27 | 1 |
| −30 | 1 |
| −31 | 1 |
| −38 | 1 |
| −38/−22,+33 | 1 |
| −43 | 1 |
| −48 | 1 |
| −7 | 1 |
| −71/−13,0,‐45 | 1 |
| −8/ | 1 |
| ≤18yrs | 1 |
| ≥10 | 1 |
| ≥15 | 1 |
| ≥18 | 1 |
| ☆ | 1 |
| β | 1 |
| öztürk | 1 |
| vasculitis | 1 |
| Ümran | 1 |
| vasculopathic | 1 |
| virus | 1 |
| virus‐2 | 1 |
| von | 1 |
| walrus | 1 |
| ward | 1 |
| werethe | 1 |
| whatsup | 1 |
| world | 1 |
| wtacr6qj | 1 |
| www.bad.org.uk/shared/get-file.ashx?itemtype=document&id=6661 | 1 |
| yhat | 1 |
| yl3j2x5p | 1 |
| yung | 1 |
| zappa | 1 |
| zorro | 1 |
| zpf2ri9k | 1 |
| zwo7e7gy | 1 |
| | | 1 |
| Çağrı | 1 |
| Öner | 1 |
| Özgür | 1 |
| Ümit | 1 |
| qgefn164 | 1 |
| pubblica | 1 |
| ktiwfcop | 1 |
| moderate | 1 |
| monocytederived | 1 |
| morbidity | 1 |
| morbiliform | 1 |
| n. | 1 |
| n.62 | 1 |
| n4v86dii | 1 |
| n=1,1410 | 1 |
| n=1,395 | 1 |
| n=22 | 1 |
| n=24 | 1 |
| n=25 | 1 |
| n=323 | 1 |
| n=34 | 1 |
| n=49 | 1 |
| n=50 | 1 |
| n=6 | 1 |
| n=6,817 | 1 |
| n=70 | 1 |
| nce | 1 |
| neurocutaneous | 1 |
| neurodermatitis | 1 |
| neuromyelitis | 1 |
| nilutamide | 1 |
| monocyte | 1 |
| mid | 1 |
| nodosum | 1 |
| microvascu | 1 |
| l'oncologia | 1 |
| l8fhy1hu | 1 |
| laboratory | 1 |
| leukocytoclastic | 1 |
| levocetrizine | 1 |
| lidose | 1 |
| lobuloplasty | 1 |
| low‐risk | 1 |
| lsewt5t2 | 1 |
| lymphopenia | 1 |
| macule | 1 |
| macules | 1 |
| macuulopapular | 1 |
| mammar | 1 |
| mc5tpnbj | 1 |
| mechanisms | 1 |
| mellifera | 1 |
| mesotherapy | 1 |
| metallopeptidases | 1 |
| mfhxac5c | 1 |
| micrococcus | 1 |
| microparticle | 1 |
| microthrombi | 1 |
| nivolumab | 1 |
| nodularis | 1 |
| psoriasica | 1 |
| pandemie | 1 |
| parainfluenza | 1 |
| part | 1 |
| pathergy | 1 |
| pediatrics | 1 |
| peplomer | 1 |
| perniosis | 1 |
| personel | 1 |
| petechiae/ | 1 |
| pimecrolimus | 1 |
| pneumocytes | 1 |
| pneumoniae | 1 |
| postherpetic | 1 |
| prognosis | 1 |
| promegestone | 1 |
| propionate | 1 |
| protease | 1 |
| protein | 1 |
| prurigo | 1 |
| pruritis | 1 |
| pruritus | 1 |
| própolis | 1 |
| pseudochilblains | 1 |
| psoriasi | 1 |
| panniculitis | 1 |
| p=0.287 | 1 |
| nonAGP | 1 |
| p=0.251 | 1 |
| nonaerosol | 1 |
| nonautoimmune | 1 |
| nonemergent | 1 |
| nonhealthcare | 1 |
| non‐at | 1 |
| novel | 1 |
| nt | 1 |
| ocrelizuma | 1 |
| odynophagia | 1 |
| omr30shm | 1 |
| onset | 1 |
| onset‐infection | 1 |
| onycholysis | 1 |
| optica | 1 |
| osteitis | 1 |
| oxendolone | 1 |
| p0km31by | 1 |
| p38-dependent | 1 |
| p:0,000 | 1 |
| p<0,05 | 1 |
| p=0.001 | 1 |
| p=0.002 | 1 |
| p=0.24 | 1 |
| biologics—51 | 1 |
| bifluranol | 1 |
| PRISMA | 1 |
| Romina | 1 |
| Riccò | 1 |
| Richa | 1 |
| Risankizumab | 1 |
| Rischio | 1 |
| Ritanavir | 1 |
| Ritux | 1 |
| Rizzoli | 1 |
| Roberge | 1 |
| Rokde | 1 |
| Rokni | 1 |
| Romana | 1 |
| Rongioletti | 1 |
| bicalutamide | 1 |
| Room | 1 |
| Roseola | 1 |
| Route | 1 |
| Rouyu | 1 |
| Rozerin | 1 |
| Rymaszewska | 1 |
| S. | 1 |
| SAPHO | 1 |
| SARS- | 1 |
| SARSCoV-2.The | 1 |
| SCARLET | 1 |
| Riccardo | 1 |
| Rhadinoviruses | 1 |
| Revision | 1 |
| Reviews | 1 |
| Rajat | 1 |
| Ralitsa | 1 |
| Ram | 1 |
| Ramalho | 1 |
| Raphaël | 1 |
| Raponi | 1 |
| Rashmi | 1 |
| Rasoul | 1 |
| Rat | 1 |
| Reactants | 1 |
| Real‐life | 1 |
| Recent | 1 |
| Recovery | 1 |
| Red | 1 |
| Ref | 1 |
| Referral | 1 |
| Renita | 1 |
| Reply | 1 |
| Reporting | 1 |
| Reports | 1 |
| Residency | 1 |
| Resistance | 1 |
| Response | 1 |
| SDs | 1 |
| SFM | 1 |
| SIG | 1 |
| ScienceDirect | 1 |
| Search | 1 |
| Searle | 1 |
| Seattle | 1 |
| Secondary | 1 |
| Sectional | 1 |
| Seirafianpour | 1 |
| Sendhil | 1 |
| September | 1 |
| Sequences | 1 |
| Serafinella | 1 |
| Serena | 1 |
| Sergio | 1 |
| Serie | 1 |
| Sexual | 1 |
| Shadows | 1 |
| Sharad | 1 |
| Sheng | 1 |
| Shetty | 1 |
| Shnakhova | 1 |
| Shrilata | 1 |
| Sicily | 1 |
| Side | 1 |
| Siena | 1 |
| Score | 1 |
| Sayyed | 1 |
| SMN | 1 |
| Saurabh | 1 |
| SP | 1 |
| SS‐A | 1 |
| STAT3 | 1 |
| STDs | 1 |
| SURF1 | 1 |
| Sabena | 1 |
| Sachin | 1 |
| Sadık | 1 |
| Saed | 1 |
| Saf | 1 |
| Salvador‐Rodriguez | 1 |
| Salvatores | 1 |
| Samaneh | 1 |
| Samochocki | 1 |
| Sanità | 1 |
| Sanna | 1 |
| Sant'Orsola | 1 |
| Sarah | 1 |
| Saraiva | 1 |
| Sarcoptes | 1 |
| Sarkar | 1 |
| Satija | 1 |
| Saudi | 1 |
| Rajan | 1 |
| Rahmatpour | 1 |
| Radiotherapy | 1 |
| Pharmacokinetics | 1 |
| Philippe | 1 |
| Philippines | 1 |
| Phone | 1 |
| Phylogeny | 1 |
| Pigatto | 1 |
| Pilot | 1 |
| Pitriasis | 1 |
| Podder | 1 |
| Policlinico | 1 |
| Polish | 1 |
| Pollozhani | 1 |
| Poonam | 1 |
| Populations | 1 |
| Portugal | 1 |
| Pour | 1 |
| Powered | 1 |
| PoznaŃski | 1 |
| Practice | 1 |
| Precaution | 1 |
| Precautions | 1 |
| Prednisolone | 1 |
| Pregnancy | 1 |
| Premises | 1 |
| Phenotypic | 1 |
| Petrov | 1 |
| Preprocedural | 1 |
| Petechiae | 1 |
| PRP | 1 |
| PSOCUBE | 1 |
| PUVA | 1 |
| PVC | 1 |
| Paediatric | 1 |
| Pajno | 1 |
| Panahi | 1 |
| Pantry | 1 |
| Papulovesicular | 1 |
| Parisella | 1 |
| Parmvir | 1 |
| Parsa | 1 |
| Parsad | 1 |
| Particulate | 1 |
| Patil | 1 |
| Patrizi | 1 |
| Patrizia | 1 |
| Patruno | 1 |
| Pattern | 1 |
| Paul | 1 |
| Paweł | 1 |
| Perlini | 1 |
| Persistence | 1 |
| Preparing | 1 |
| Prepubertal | 1 |
| Radiology | 1 |
| Q | 1 |
| Qiu | 1 |
| Qiuning | 1 |
| QoL | 1 |
| QoL. | 1 |
| Quadros | 1 |
| Qual | 1 |
| Quality | 1 |
| RA | 1 |
| RAS | 1 |
| RB | 1 |
| RBD | 1 |
| RCRDC | 1 |
| RED‐ZONE | 1 |
| RESULT | 1 |
| RF- | 1 |
| RK | 1 |
| RNAdependent | 1 |
| RR=0.87 | 1 |
| Rabbit | 1 |
| Race | 1 |
| Rachita | 1 |
| Racial | 1 |
| Radiol | 1 |
| Q&A | 1 |
| Pustular | 1 |
| Present | 1 |
| Purifying | 1 |
| Primate | 1 |
| Procedures | 1 |
| Prof | 1 |
| Profiling | 1 |
| Program | 1 |
| Project | 1 |
| Prone | 1 |
| Propolis | 1 |
| Proposed | 1 |
| Prospective | 1 |
| Prostate | 1 |
| Protein | 1 |
| Pruritic | 1 |
| Psychiatric | 1 |
| Psychiatry | 1 |
| Psychological | 1 |
| Public | 1 |
| Publication | 1 |
| Publications | 1 |
| Publishing | 1 |
| Pubmed | 1 |
| Pulmonary | 1 |
| Puneet | 1 |
| Sikh | 1 |
| Sikhs | 1 |
| Silvestri | 1 |
| Wei | 1 |
| 1 | |
| Wilk | 1 |
| Willebrand | 1 |
| Williams | 1 |
| Witney | 1 |
| Workflow | 1 |
| Workplaces | 1 |
| Worldometer | 1 |
| Worlometers | 1 |
| Yang | 1 |
| Ying | 1 |
| Yogendra | 1 |
| York | 1 |
| Youssef | 1 |
| Yu | 1 |
| Yuanzhuo | 1 |
| Yuksel | 1 |
| Yuxin | 1 |
| Zbigniew | 1 |
| Zekayi | 1 |
| Zeynep | 1 |
| Zhong | 1 |
| Zika | 1 |
| 1 | |
| Web | 1 |
| Zoonotic | 1 |
| Way | 1 |
| Varbanov | 1 |
| Vascular | 1 |
| Vassallo | 1 |
| Vectra | 1 |
| Vedamurthy | 1 |
| Venkataram | 1 |
| Veras | 1 |
| Versus | 1 |
| Vertical | 1 |
| Vibrio | 1 |
| Victoria | 1 |
| Villani | 1 |
| Vinay | 1 |
| Vircell | 1 |
| Virtual | 1 |
| Viruses | 1 |
| Vivian | 1 |
| Viviani | 1 |
| WA | 1 |
| WHO | 1 |
| Wambier | 1 |
| Warriors | 1 |
| Washenik | 1 |
| Zone | 1 |
| Zumla | 1 |
| Vandana | 1 |
| apalutamide | 1 |
| apy | 1 |
| areata | 1 |
| artepillin | 1 |
| arthralgia | 1 |
| association | 1 |
| atherogenesis | 1 |
| aureus | 1 |
| autbreak | 1 |
| autoimmuni | 1 |
| ay | 1 |
| azeleic | 1 |
| b. | 1 |
| b1e3d4605af0cfc7dad1b73d331b8f14a01f8156 | 1 |
| b3wd182c | 1 |
| b783bdbe56867e2eb7221d5b34451060025c428d | 1 |
| b96c6dde300db2d5095948da748e97d6ad7e4527 | 1 |
| basigin | 1 |
| bb93ed9107b350c45a13bbf09515d6eb969265d9 | 1 |
| bdb9c88c7f0c8d65993b982c5213c0c635b0e599 | 1 |
| ben | 1 |
| benzoiyl | 1 |
| benzonatate | 1 |
| beta-1a | 1 |
| applicabili | 1 |
| antifibrin | 1 |
| Zuzanna | 1 |
| antibody | 1 |
| a223ece1cfd7716fb0cfda3bf33588b611f9a019 | 1 |
| a24d9709d1cbc2ac8a5befe986b4e3691f5a3156 | 1 |
| a69e175ff426a2a483aad1f4cb066af413dd74bd | 1 |
| aCL | 1 |
| aPL | 1 |
| aarcjyia | 1 |
| abutfxtf | 1 |
| ac1d20805820c76d912bb1f344bed60e92a7df34 | 1 |
| acid | 1 |
| acneiform | 1 |
| acquisita | 1 |
| aec0e2954de84fd46977c75529089eff46973c88 | 1 |
| alfa | 1 |
| alfaestradiol | 1 |
| alitretinoin | 1 |
| alprazolam | 1 |
| aminoglutethimide | 1 |